Tele-STELLA for Alzheimer's Caregivers (Tele-STELLA Trial)

N/A

Waitlist Available

Led By Allison Lindauer, PhD

Research Sponsored by Oregon Health and Science University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a new intervention to help caregivers of people with dementia understand and reduce the distressing behaviors that come with the progressive disease. The intervention, Tele-STELLA, is conducted over video conference and includes professional "Guides" who help caregivers ("Care Partners") identify strategies to address upsetting behaviors. The goal is to reduce Care Partner burden.

Who is the study for?

This trial is for family members caring for individuals with moderate to late-stage Alzheimer's or related dementias, who are dealing with at least two distressing behaviors from the person they're caring for that happen three or more times a week.

What is being tested?

Tele-STELLA, a videoconference-based program, is being tested. It aims to educate and support caregivers by helping them manage difficult behaviors associated with advanced dementia through sessions with professional Guides.

What are the potential side effects?

Since Tele-STELLA is an educational and supportive intervention rather than a medication, it may not have traditional side effects. However, participants might experience emotional discomfort discussing challenging caregiving experiences.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Revised Memory and Behavior Problems Checklist

Secondary study objectives

4 item Zarit Burden Interview

Center for Epidemiological Studies Depression Scale

Computer Self-Efficacy and Computer Anxiety Survey

+5 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Care PartnersExperimental Treatment1 Intervention

Based on previous work, we will recruit up to 75 Care Partners and their 75 care recipients with dementia. This allows for 20% attrition. We will recruit participants from Alzheimer's Disease Research Centers (ADRCs) and other national locations.

Do I qualify?Apply below to find out